UGro Capital sells Rs 200.9494 crore of stressed loans to an ARC

UGro Capital Limited sold 1,036 stressed-loan accounts with Rs 200.9494 crore of aggregate principal outstanding to an asset reconstruction company, or ARC, in the half year ended September 30, 2026, receiving Rs 180.8391 crore and reversing Rs 18.0167 crore of excess provisions.

What stressed loans did UGro Capital transfer to the ARC?

UGro Capital transferred 1,036 stressed-loan accounts to an ARC during the half year ended September 30, 2026, with aggregate principal outstanding of Rs 200.9494 crore. The disclosure categorises the loans as non-performing assets, or NPAs, and records no transfers to permitted transferees or other transferees in the accompanying table.

The transferred pool had a weighted average residual tenor of 4.79 years. This measure describes the remaining contractual duration of the sold loans, rather than the age of borrower accounts or the period for which loans had been classified as stressed. The filing does not name the ARC, identify underlying borrower sectors, or give a recovery estimate for the transferred portfolio.

UGro Capital made the disclosure under Reserve Bank of India, or RBI, financial-statement presentation and disclosure directions issued in November 2025 and updated on July 1, 2026. UGro Capital describes itself as a non-deposit-taking non-banking financial company, or NBFC, classified by the RBI as an NBFC Middle Layer entity.

How did the ARC sale compare with UGro Capital's book value?

UGro Capital received Rs 180.8391 crore of aggregate consideration for loans carrying a net book value of Rs 162.8223 crore at transfer. Consideration was Rs 18.0168 crore above carrying value, while the company reported Rs 18.0167 crore of excess provisions reversed to the statement of profit and loss for the half year ended September 30, 2026.

The Rs 200.9494 crore principal outstanding was Rs 20.1103 crore higher than the Rs 180.8391 crore consideration. Principal outstanding and consideration are different disclosed measures: the former is the contractual loan principal, while consideration is the amount paid for the transferred portfolio. The filing does not provide a recovery forecast, sale discount rate, or account-level pricing detail.

The net book value of Rs 162.8223 crore was Rs 38.1271 crore below the transferred pool's Rs 200.9494 crore principal outstanding. UGro Capital identifies Rs 18.0167 crore as excess provisions reversed on the sale, but does not separately state total provision coverage on the pool immediately before transfer. It also does not state whether consideration was received as cash, security receipts, or a combination of instruments.

What did the provision reversal mean for UGro Capital's results?

UGro Capital reversed Rs 18.0167 crore of excess provisions to profit and loss in connection with the ARC sale, for which it reported Rs 180.8391 crore of consideration and Rs 162.8223 crore of net book value. The stated accounting effect concerns the sale transaction and is not a forecast of recoveries the ARC may realise from the Rs 200.9494 crore principal pool.

For the half year ended September 30, 2026, UGro Capital reported impairment on financial instruments of Rs 144.6564 crore, up from Rs 92.0027 crore in the half year ended September 30, 2025. The Rs 18.0167 crore reversal was therefore below the impairment charge in either half-year period and should be considered alongside, rather than as a replacement for, the broader impairment expense.

Standalone profit after tax was Rs 98.0844 crore in the half year ended September 30, 2026, compared with Rs 77.4416 crore a year earlier. In the September 2026 quarter, profit after tax was Rs 37.3698 crore, below Rs 60.7146 crore in the June 2026 quarter and Rs 43.3112 crore in the September 2025 quarter. The filing does not isolate the reversal's exact contribution to quarterly or half-year profit.

How did UGro Capital's reported asset quality change?

UGro Capital reported a gross Stage 3 ratio of 2.73% at September 30, 2026, down from 3.66% at March 31, 2026 and 2.99% at September 30, 2025. Gross Stage 3 is the company's disclosed measure of loans in its highest credit-risk category, and the reduction occurred in the same half year as the ARC transfer.

The net Stage 3 ratio was 1.73% at September 30, 2026, compared with 2.24% at March 31, 2026 and 1.66% a year earlier. Gross Stage 3 improved both sequentially and year on year, while net Stage 3 improved from March 2026 but was 0.07 percentage points above the September 2025 level. The filing does not attribute those movements solely to the Rs 200.9494 crore transfer.

Loans on UGro Capital's standalone balance sheet rose to Rs 9,361.193 crore at September 30, 2026 from Rs 8,314.5282 crore at March 31, 2026. The Rs 1,046.6648 crore increase in the reported loan balance occurred while UGro Capital sold stressed loans and continued loan activity. The source does not provide a reconciliation separating originations, repayments, transfers and fair-value movements.

What other loan transfers and acquisitions did UGro Capital disclose?

UGro Capital separately reported transfers to banks and NBFCs with aggregate principal outstanding of Rs 536.5861 crore in the half year ended September 30, 2026. Consideration received on those transfers was Rs 482.9275 crore, and the weighted average maturity was 9.03 years; the table explicitly excludes loans transferred through co-lending arrangements.

For those bank and NBFC transfers, UGro Capital retained a 10.00% beneficial economic interest and disclosed tangible-security coverage of 217.88% for secured loans transferred. These figures cover a different transfer category from the stressed-loan ARC sale, whose table reports 1,036 accounts and Rs 200.9494 crore of principal but does not state a retained beneficial interest.

UGro Capital also acquired loans not in default from NBFCs during the same half year. Those acquired loans had aggregate principal outstanding of Rs 18.7212 crore, for which consideration paid was Rs 16.8491 crore, with a weighted average residual maturity of 3.62 years. UGro Capital additionally said it did not acquire any stressed loans under the relevant RBI notification during the period.

Conclusion

UGro Capital's September 2026 disclosure records a disposal of Rs 200.9494 crore of stressed-loan principal through 1,036 accounts sold to an ARC. Aggregate consideration of Rs 180.8391 crore exceeded the Rs 162.8223 crore net book value, alongside a Rs 18.0167 crore excess-provision reversal, while gross Stage 3 declined to 2.73% from 3.66% at March 2026.

The next disclosed event to watch is the National Company Law Tribunal's final hearing on November 20, 2026 for the proposed amalgamation of Profectus Capital Private Limited with UGro Capital. UGro Capital filed its final-approval petition on September 25, 2026 after equity shareholders, secured creditors and unsecured creditors approved the scheme at meetings held on September 22, 2026.